394
Views
18
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study

, , &
Pages 1033-1040 | Received 05 Apr 2013, Accepted 18 Jun 2013, Published online: 23 Jul 2013

References

  • Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11:909–18.
  • Hjortswang H, Ström M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998;93:2203–11.
  • Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577–94.
  • Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 2008;14:390–400.
  • Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8:458–66.
  • Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006;12:1068–83.
  • Ibrahim CB, Aroniadis C, Brandt LJ. On the role of ischemia in the pathogenesis of IBD: A review. Inflamm Bowel Dis 2010;16:696–702.
  • Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder R E, Wakefield A J. Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996;38:733–7.
  • Tsuchiya M, Miura S, Asakura H, Hibi T, Tanaka T, Aiso S, et al. Angiographic evaluation of vascular changes in ulcerative colitis. Angiology 1980;31:147–53.
  • Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, et al. Cyclosporine versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012;380:1909–15.
  • Andersson P, Söderholm JD. Surgery in ulcerative colitis: indication and timing. Dig Dis 2009;27:335–40.
  • Hanson B, MacDonald R, Shaukat A. Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review. Dis Colon Rectum 2012;55:1081–95.
  • Mendenhall WM, McKibben BT, Happe BS, Nichols RC, Henderson RH, Mendenhall NP. Management of radiation proctitis. Am J Clin Oncol 2012; Epub ahead of print.
  • Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996;334:1642–8.
  • Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 1994;19:202–5.
  • Brady CE 3rd, Cooley BJ, Davis JC. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen. Gastroenterology 1989;97:756–60.
  • Nelson EW Jr, Bright DE, Villar LF. Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management. Dig Dis Sci 1990;35:1561–5.
  • Colombel JF, Mathieu D, Bouault JM, Lesage X, Zavadil P, Quandalle P, et al. Hyperbaric oxygenation in severe perineal Crohn's disease. Dis Colon Rectum 1995;38:609–14.
  • Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 1998;43:512–18.
  • Buchman AL, Fife C, Torres C, Smith L, Aristizibal J. Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 2001;33:337–9.
  • Demirturk L, Ozel M, Yazgan Y, Buchman AL. Therapeutic efficacy of hyperbaric oxygenation in ulcerative colitis refractory to medical treatment. J Clin Gastroenterol 2002;35:286–7.
  • Gürbüz AK, Elbüken E, Yazgan Y, Yildiz S. A different therapeutic approach in patients with severe ulcerative colitis: hyperbaric oxygen treatment. South Med J 2003;96:632–3.
  • Karkumov M, Nikolov N, Georgiev L, Mitreva D, Uzunova A. Hyperbaric oxygenation as a part of the treatment of chronic ulcerohemorrhagic colitis. Vutr Boles 1991;30:78–80.
  • Kuroki K, Masuda A, Uehara H, Kuroki A. A new treatment for toxic megacolon. Lancet 1998;352:782.
  • Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718–23.
  • Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, et al. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 1997;17:154–9.
  • Ratzenhofer-Komenda B, Favory R, Welslau W, Smolle-Juttner FM, Mathieu D. Physiologic effects of Hyperbaric oxygen transport and tissue pressure. In Mathieu D, editors. Handbook on hyperbaric medicine. 1st edition. Dordrecht: Springer The Netherlands; 2006. pp 49–73.
  • Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res 2012;2:6.
  • Sullivan M, Karlsson J, Ware J. The Swedish SF-36 Health Survey-1. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349–58.
  • Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.